Bedel Financial Consulting’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-925
| Closed | -$9K | – | 819 |
|
|
2022
Q1 | $9K | Hold |
925
| – | – | ﹤0.01% | 699 |
|
|
2021
Q4 | $7K | Hold |
925
| – | – | ﹤0.01% | 737 |
|
|
2021
Q3 | $9K | Hold |
925
| – | – | ﹤0.01% | 696 |
|
|
2021
Q2 | $9K | Buy |
925
+650
| +236% | +$6.32K | ﹤0.01% | 697 |
|
|
2021
Q1 | $3K | Hold |
275
| – | – | ﹤0.01% | 816 |
|
|
2020
Q4 | $3K | Hold |
275
| – | – | ﹤0.01% | 722 |
|
|
2020
Q3 | $2K | Hold |
275
| – | – | ﹤0.01% | 739 |
|
|
2020
Q2 | $3K | Hold |
275
| – | – | ﹤0.01% | 663 |
|
|
2020
Q1 | $2K | Hold |
275
| – | – | ﹤0.01% | 704 |
|
|
2019
Q4 | $3K | Hold |
275
| – | – | ﹤0.01% | 659 |
|
|
2019
Q3 | $2K | Hold |
275
| – | – | ﹤0.01% | 675 |
|
|
2019
Q2 | $3K | Hold |
275
| – | – | ﹤0.01% | 626 |
|
|
2019
Q1 | $4K | Hold |
275
| – | – | ﹤0.01% | 600 |
|
|
2018
Q4 | $4K | Hold |
275
| – | – | ﹤0.01% | 571 |
|
|
2018
Q3 | $6K | Hold |
275
| – | – | ﹤0.01% | 537 |
|
|
2018
Q2 | $7K | Hold |
275
| – | – | 0.01% | 518 |
|
|
2018
Q1 | $5K | Buy |
+275
| New | +$5K | ﹤0.01% | 547 |
|